![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Indiana University School of Medicine |
---|---|
Information provided by: | Indiana University |
ClinicalTrials.gov Identifier: | NCT00308295 |
The main goal of this study is to determine whether the American Heart Association-recommended fish oil dose is efficacious, safe, and tolerable in hemodialysis patients. The secondary objective is to test the effects of fish oil supplementation on inflammatory and cardiovascular markers.
Condition | Intervention |
---|---|
End-Stage Renal Disease Patients on Hemodialysis |
Drug: Fish oil capsules Drug: matched placebo capsules |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients |
Estimated Enrollment: | 27 |
Study Start Date: | April 2006 |
Estimated Study Completion Date: | May 2006 |
Ages Eligible for Study: | 18 Years to 82 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Exclusion Criteria:
United States, Indiana | |
VeteransAdministration Hospital | |
Indianapolis, Indiana, United States, 46202 | |
Indiana University Nephrology Clinics | |
Indianapolis, Indiana, United States, 46202 |
Principal Investigator: | Allon Friedman, MD | Indiana University |
Study ID Numbers: | 0512-13 |
Study First Received: | March 27, 2006 |
Last Updated: | October 15, 2007 |
ClinicalTrials.gov Identifier: | NCT00308295 |
Health Authority: | United States: Institutional Review Board |
Renal Insufficiency Urologic Diseases Renal Insufficiency, Chronic |
Kidney Failure, Chronic Kidney Diseases Kidney Failure |